Pharmacovigilance Outsourcing: Are You Really in Control of Your Vendor Oversight?

Pharmacovigilance Outsourcing: Are You Really in Control of Your Vendor Oversight?

As pharmacovigilance (PV) outsourcing becomes the norm, one question takes centre stage: how can companies maintain clear oversight and regulatory control when essential safety activities are performed by external vendors?

With the introduction of EU Regulation 2025/1466, regulators now place stronger expectations on vendor oversight and QPPV accountability. Marketing Authorisation Holders (MAHs) are expected to show transparent, documented evidence that their vendors are monitored in real time not simply managed through contracts.

So, if your PV operations are outsourced, ask yourself: can you prove control, or do you just assume it?

Do your oversight logs tell a complete story?

Inspectors frequently ask: “Show me how you oversee your vendor.” Could you provide that evidence on the spot?

An oversight log should do more than track meetings, it should tell a story of decision‑making, escalation, and intervention. Does yours capture CAPAs, deviations, and vendor performance trends? Does it demonstrate active involvement from the Qualified Person for Pharmacovigilance (QPPV)?

A well‑maintained oversight log builds regulatory confidence and shows that control isn’t just theoretical it’s continuous and active.

Are your PV dashboards adding real value?

Dashboards should give visibility at a glance — but do they? A well‑designed pharmacovigilance dashboard offers instant visibility into vendor performance, but only if the right data are chosen. Are you tracking metrics that matter such as case processing timelines, literature screening compliance, and audit actions?

Could your dashboard help spot early warning signals, or is it simply a report generator? Can the QPPV use them to challenge performance trends and trigger intervention when needed?

If an overseas vendor’s backlog doubled overnight, how quickly would your dashboard alert you to the risk?

Do your KPIs measure compliance or convenience?

very PV team tracks key performance indicators (KPIs), but meaningful oversight depends on what you measure. Are your KPIs risk‑based and aligned with regulatory expectations or just convenient for reporting?

For example, do you monitor ICSR submission timeliness, signal validation intervals, and deviation closure rates? And more importantly, does your QPPV review and challenge those KPIs regularly? Trends are only useful when they drive accountability.

Remember, consistency means little if the wrong measures are being reported. Oversight requires both numbers and narrative

Is your governance framework inspection‑ready?

Strong governance structures connect performance data to regulatory accountability. But are your governance meetings producing actionable insight or just documentation?

Do your SDEAs and contracts guarantee system access, data visibility, and escalation authority for the QPPV? When inspectors review your meeting minutes and CAPA trackers, will they see a traceable record of oversight interventions?

A governance framework should be dynamic, evolving with vendor complexity, product risk, and inspection findings.

Are you using risk‑based oversight effectively?

Regulators recognise that not every vendor carries equal risk but does your oversight reflect that?

Do you use a risk‑based monitoring approach, supported by tools like a vendor performance heat map? If you rated your vendors today on compliance, quality, and responsiveness, how many would show green and how many would need urgent attention?

A visual heat map can demonstrate to inspectors that your PV system not only monitors vendors, but prioritises oversight based on real risk data.

Final thought: inspection readiness starts with good questions

Pharmacovigilance vendor oversight isn’t a static or box‑ticking exercise; it’s a test of both evidence and engagement. When the next inspection arrives, will your documentation, and your team be able to demonstrate that you genuinely own your PV system?

At PharmaGuard Consultancy Ltd, we help MAHs and QPPVs design robust, risk‑based oversight frameworks, streamline PV dashboards, and validate KPIs for compliance confidence.

Whether you’re preparing for inspection or refining outsourced PV operations, our expertise ensures you can confidently say: yes, we are in control.

👉 Get in touch to explore how our pharmacovigilance and compliance expertise can strengthen your next move.